We are live on ! Find out more
TGV

TRV GP V Portfolio holdings

AUM $401M
1-Year Est. Return 284.76%
This Fund
S&P 500
This Quarter Est. Return
+26.04%
1 Year Est. Return
+284.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$429M
AUM Growth
+$75.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPP
1
Rapport Therapeutics
RAPP
$2.01B
$216M 50.44%
7,135,233
SEPN
2
Septerna Inc
SEPN
$1.51B
$173M 40.38%
6,215,591
MAZE
3
Maze Therapeutics
MAZE
$1.59B
$39.4M 9.18%
950,800

Similar funds

TRV GP V's Q4 2025 Portfolio in Review

As of Q4 2025, TRV GP V held 3 positions worth $429M, up 21% from $353M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 0%. TRV GP V opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP V's ten largest holdings make up 100% of its $429M portfolio in Q4 2025.
  • TRV GP V opened 0 new positions and closed 0 in Q4 2025.
  • TRV GP V's portfolio value rose 21% quarter-over-quarter to $429M.

Based on TRV GP V's 13F filing for Q4 2025, filed 13 Feb 2026.